Zepp Health Corporation Sponsored ADR
ZEPP Technology Consumer Electronics
Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.
- Revenue
- +6.93%
- EPS
- −46.9%
- Free cash flow
- −103.7%
- Total debt
- +26.4%
Quarter to June 2026, against a year earlier
Follow ZEPP
Alert me
Zepp Health Corporation Sponsored ADR (ZEPP) EV/Sales
As of 5 November 2026, Zepp Health Corporation Sponsored ADR (ZEPP) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.0× (September 2018) to 4.3× (September 2025); the current reading is higher than 31% of that period. That is below the Consumer Electronics industry median of 0.9× and below the Technology sector median of 2.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.7× | 540.55% |
| FY2024 | 0.3× | 44.04% |
| FY2023 | 0.2× | (44.51%) |
| FY2022 | 0.3× | (74.57%) |
| FY2021 | 1.3× | 167.95% |
| FY2020 | 0.5× | (18.19%) |
| FY2019 | 0.6× | 7.27% |
| FY2018 | 0.5× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.4× | (49.50%) |
| Mar 2026 | 0.8× | (52.79%) |
| Dec 2025 | 1.7× | (46.81%) |
| Sep 2025 | 3.1× | 1,120.25% |
| 31 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| WLDS Wearable Devices Ltd. compare | −44.5× |
| MSN Emerson Radio Corporation compare | −0.9× |
| FEBO Fenbo Holdings Limited compare | n/m |
| UEIC Universal Electronics Inc. compare | 0.1× |
| FOXX Foxx Development Holdings Inc. compare | 0.2× |
| ZEPP Zepp Health Corporation Sponsored ADR | 0.2× |
| FXHO UTime Limited compare | 0.5× |
| KOSS Koss Corporation compare | 0.9× |
| AXIL AXIL Brands, Inc. compare | 0.9× |
| Consumer Electronics industry median | 0.9× |
| Technology sector median | 2.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)